Skip to main content
    P

    Prothena Corporation plc (PRTA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.97
    -0.19 (-2.33%)

    Market Cap: $419.01M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Prothena Corporation plc (PRTA) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Prothena Corporation (PRTA) trades at 7.8x sales and 1.5x book value. Its P/S of 7.8x is below its 5-year median of 11.8x. Its forward P/E is 33.9x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E33.9x
    Price to sales7.8x
    Price to book1.5x
    PEGN/A
    FCF yield-7.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 84.1% below 49.1x and its P/B is 31.8% below 2.2x.

    MultipleCurrent5-year median10-year median
    P/S7.8x11.8x49.1x
    P/B1.5x2.2x2.2x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 109 to 120 months (10-year).

    Valuation History

    Over the 9 of the 10 year ends shown that have a P/S, its P/S ranged from 5.5x in 2024 to 775.6x in 2019.

    Year endPriceP/EP/SP/B
    2025$9.55N/A53.1x1.8x
    2024$13.85N/A5.5x1.5x
    2023$36.34N/A21.3x3.5x
    2022$60.25N/A59.7x5.2x
    2021$49.4045.3x11.1x4.9x
    2020$12.01N/A562.0x2.6x
    2019$15.83N/A775.6x2.3x
    2018$10.30N/A426.7x1.3x
    2017$37.49N/A51.8x3.5x
    2016$49.19N/AN/A4.7x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PRTA

    What is PRTA's forward P/E ratio?

    Prothena Corporation has a forward P/E ratio of 33.9x.

    Is PRTA stock overvalued?

    GNG's valuation label for PRTA is Fairly valued.

    What is PRTA's price to sales ratio?

    Prothena Corporation has a price to sales ratio of 7.8x.